Quach, H., Popat, R., Chen, W., Kwok, M., Yee, A., Jiang, Z., Xavier, F., Callander, N., Ho, M. Y., Bal, S., Low, M., Sborov, D., Man, G., Cheng, H., Idoine, A., Wang, X., Agarwal, A., Dhakal, B. (2025). Initial phase 1b/2 study results with sonrotoclax (BGB-11417) in combination with carfilzomib and dexamethasone in patients with t(11;14)-positive relapsed/refractory multiple myeloma. Blood. https://doi.org/10.1182/blood-2025-102